Huilin Huang
Molecular Biology · Cancer Cell · 2016–2020
A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 234 citations into it
Whom Huilin Huang trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Huilin Huang overall
Papers from Huilin Huang's perspective
Ordered by how strongly the researchers Huilin Huang trusts endorse each paper. Same corpus, a different order for every researcher.
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq (Nature)
- N6-methyladenosine Modulates Messenger RNA Translation Efficiency (Cell)
- N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO (Nature Chemical Biology)
- Structural basis of N6-adenosine methylation by the METTL3–METTL14 complex (Nature)
- m6A RNA methylation promotes XIST-mediated transcriptional repression
- Single-nucleotide resolution mapping of m6A and m6Am throughout the transcriptome (Nature Methods)
- METTL3 promotes translation in human cancer cells (Molecules and Cells)
- m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells (Cell Reports)
- Reversible methylation of m6Am in the 5′ cap controls mRNA stability (Nature)
- ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. (JIM - Journal of Immunological Methods)
Their papers
- FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase (2016) — 1,299 citations
- Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation (2018) — 2,518 citations
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling (2017) — 977 citations
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification (2017) — 860 citations
- m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer (2020) — 1,040 citations
- RNA N6-methyladenosine modification in cancers: current status and perspectives (2018) — 614 citations
- Targeting FTO suppresses cancer stem cell maintenance and immune evasion (2020) — 658 citations